In mice models of myeloid leukemia and non-Hodgkin’s lymphoma, anti-CD47 were effective in clearing cancer cells while normal cells were unaffected.
En modelos de rato de leucemnia mieloide e linfoma non de Hodgkin, os anti-CD47 foron efectivos para eliminar células cancerosas á vez que as células normais non foron afectadas.